30-Day in-Hospital Mortality After Coronary Artery Bypass Graft (CABG) and Aortic Valve Replacement (AVR)

Identifying Attributes

Care Settings
Hospital Care
Country
Canada
Publishing Organisation
Canadian Institute for Health Information (CIHI)
Type of Quality Indicator
Outcome
IOM Quality Dimension
Safety
Domain
Readmission

Defining Attributes

Definition

This indicator calculates the risk-adjusted rate of all-cause in-hospital deaths occurring within 30 days for patients undergoing coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgery.

Numerator

Number of hospitalisation episodes in the denominator that resulted in an in-hospital death within 30 days of CABG and AVR surgery.

Denominator

Number of hospitalisation episodes for patients age 18 and older who underwent a CABG and AVR surgery.

Exclusions

Episodes with other valve procedures or core concomitant procedures.

Use of Risk Adjustment
Yes
Risk Adjustments

Age, sex, urgent admission, shock, NSTEMI, previous acute myocardial infarction, previous cardiac surgery, cardiac dysrhythmias, multiple cardiac interventions, acute renal failure, Charlson Index.

Stratifications

By reporting level: National, Province/Territory, Facility.

Data Attributes

Type of Data Collection
Standardised clinical data
Data Collection Methods

Discharge Abstract Database (DAD), Human Metabolome Database (HMBD), National Ambulatory Care Reporting System (NACRS)

Frequency of Data Collection
Annually
Frequency of Data Collection in Days
365
Reporting Methods
Reporting Frequency
Annually
Reporting Frequency in Days
365
Indicator Has Recommended Targets
No

Source and Reference Attributes

Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
23 July 2025